Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, ...

In the last three months, 6 analysts have published ratings on Labcorp Holdings (NYSE:LH), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth ...

Labcorp Holdings Inc. LH, or Labcorp, is positioning itself for sustained growth with a series of strategic acquisitions and partnerships. With a growing emphasis on cell and gene therapy, the company ...

Labcorp Holdings ( ($LH) ) has issued an update. On December 30, 2025, Labcorp announced it would participate in a fireside chat at the 44th ...

Labcorp's share price has materially outperformed the S&P 500 over the past 12 months. It stands to benefit from expanded testing as schools reopen, and could use its cash windfall towards accretive M ...

Laboratory Corporation of America Holdings or LabCorp LH is well poised for growth in the coming quarters, backed by strength in the Covance Drug Development arm. The company’s plans to expand in high ...

Labcorp Holdings Inc (LH) stock reached a 52-week high of 289.61 USD, marking a significant milestone for the $24 billion healthcare diagnostics giant. According to InvestingPro analysis, the stock ...

The coronavirus pandemic is having a big impact on LabCorp, but maybe not in the way you expected. Millions of tests for COVID-19 have been performed in the U.S., but experts and politicians continue ...